• List of Tentative Meeting Dates for All CDER Advisory Committees
• List of Committee Members
• Committee Charter
• CDER Contacts

• 2004 FDA Advisory Committee Calendar  Meeting information includes center, date, time and location; agenda, presentation procedures, contact persons, and links to the Federal Register notice.
  
  

• 2004 Drug Safety and Risk Management Meetings. Links to draft agendas, questions, transcripts and other meeting information. (None held to date)

2003     2002

Date:  7/17/2002
Topic:  The committee will discuss ways to improve the usefulness of consumer medication information (CMI) distributed with prescriptions being filled at the nation's pharmacies. Findings of a recent FDA- sponsored study showed that CMI is currently being distributed with more than 85 percent of prescriptions and that scientific accuracy of the materials is high, but the usefulness of materials is variable due largely to omissions of important risk and benefit information. The committee will consider: (1) Potential causes of insufficiencies in CMI, including current practices of the parties involved in developing and processing CMI and pharmacy practices that may affect the distribution and content of CMI, and (2) potential interventions to address causes of CMI insufficiencies in the current system, and scientific methods to assess and monitor whether effective communication of key information to patients is occurring.